MA16.03 CRISPR Screen Reveals XPO1 as a Therapeutic Target Strongly Sensitizing to First and Second Line Therapy in Small Cell Lung Cancer
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI